Importantly, when the same T cells are transferred into HBV transgenic mice whose myeloid dendritic cells (mDCs) were simultaneously activated by agonistic antibodies against CD40 (αCD40), PD-1 induction is suppressed and the T cells differentiate normally, inhibit HBV antigen expression, and cause liver disease. Here, CD40 is linked to liver disorder.